Edwards Lifesciences Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 25.8% | 23.4% | 17.7% |
| FY2022 | 26.2% | 23.8% | 18.4% |
| FY2023 | 21.1% | 19.4% | 15.0% |
| FY2024 | 41.8% | 39.4% | 32.0% |
| FY2025 | 10.4% | 9.8% | 7.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 25.8% | 23.4% | 17.7% |
| FY2022 | 26.2% | 23.8% | 18.4% |
| FY2023 | 21.1% | 19.4% | 15.0% |
| FY2024 | 41.8% | 39.4% | 32.0% |
| FY2025 | 10.4% | 9.8% | 7.8% |